- Karin C. Lødrup Carlsen (N) Chair
- Vivi Schlunssen (DK)
- Knut Øymar (N)
- Maria Jernmalm (S)
- Nanna Fyhrquist (F)
- Sigurveig Sigurdardottir (IS)
This Nordic Allergy symposium reaches out to clinicians and researchers within all aspects of allergology, and the programme provides an excellent opportunity to discuss state of the art allergy practice in the Nordic countries. The highly profiled as well as up-and-coming young speakers come from all the Nordic countries as well as from EAACI.
1100-1200 NFAI general assembly. Members of NFAI, Norway
1200-1300 LUNCH 1 hour
1300-1310 WELCOME to NFA. Jon Olav Hunderi, Norway
1310-1410 The atopic march and early allergy
The pros, cons and implications of the atopic march.
Sigurveig T Sigurdardottir, Iceland
Early recognition and presentation of allergy.
Karin C. Lødrup Carlsen, Norway
1410-1430 20’ BREAK
1430-1600 Advances in Allergy diagnostics
BAT, MAT and beyond.
Lars Poulsen, Denmark
Discussion: laboratory tests in allergy
CRD: clinical value in inhalant and food allergy.
Anna Asarnoj, Sweden
Discussion: when to use and not to use CRD?
1600-1620 20’ BREAK
1620-1650 News from EAACI
Strategies to improve outcomes in rhinitis care anno 2019.
Peter Hellings, Belgium
1700 NFA GENERAL ASSEMBLY/Get-to-gether
0830-1030 Nature and nurture: the microbiome and allergy development in “the Nordic countries”
Cutting edge: Host-microbe interactions in health and disease
Knut Rudi, Norway
Gene-microbiome interaction in allergic disease
Klaus Bønnelykke, Denmark
Microbiome- immune function
Maria Jenmalm, Sweden
Environmental exposure, human health and allergies
Nanna Fuhrquist, Finland
1030-1100 30’ BREAK
Reducing the allergy burden in Nordic countries in 2019
A paradigm shift by the Finnish Allergy Programme 2008-2018 Tari Haahtela Finland
1300-1430 Choosing Wisely in allergic disease
Choosing wisely; what and why
Kjetil Størdal, Norway
Knut Øymar, Norway
Torgeir Storaas, Norway
Mika Makela, Finland
1430-1500 30’ BREAK
1500-1730 Modifiable factors in allergic disease, primary, secondary & tertiary prevention
Current primary allergy prevention in “Norden”
Susanne Halken, Denmark
Skin barrier - basic concepts and role in primary prevention
Eva Maria Rehbinder, Norway
Are skin interventions in infancy useful to reduce atopic dermatitis?
Håvard O Skjerven, Norway
Nature-derived microbiome exposure to reduce allergic sensitisation
Aki Sinkkonen, Finland
1630-1645 15’ BREAK
Marit Westman, Sweden
Discussion and close for Thursday session
0830-1000 Research around "Norden”
News from the Finnish Russian Karelia Allergy project
Joseph Ndika, Finland
Probiotics for preventing allergies
Melanie Rae Simpson, Norway
Atopic dermatitis at preschool age and contact allergy in adolescence
Anna Bergström, Sweden
1000-1030 30’ BREAK
1030-1130 Old diseases, new challenges?
Eosinophil oesophagitis an emerging epidemic?
Ari Vidir Axelsson, Iceland
Drug allergy during anaesthesia
Lene Heise Garvey, Denmark
AIT in the pipeline, including Intralymphatic Immunotherapy
Lars Ahlbeck, Sweden
1145-1300 Oral immunotherapy in Nordic countries in 2020
Geir Håland, Norway
Egg, milk OIT
Mika Makela, Finland
Jon Olav Hunderi, Norway
Chair: Jon Olav Hunderi, Hospital trust Østfold. E-mail: email@example.com